Abstract:BACKGROUND AND OBJECTIVE:Colorectal cancer is one of the most common malignant cancers in the world. Although the clinicopathologic staging is the golden criterion for the prognosis at present, the optimum prognostic criteria for colorectal cancer should be a combination of the clinicopathologic staging and the molecular markers. However, there are currently no molecular markers available for the prognosis of colorectal cancer. Several tumor-suppressor genes associated with colorectal cancer have been mapped at the 18q21-23 region. In this study we detected the frequency of loss of heterozygosity (LOH) at chromosome 18q and investigated the relationship between LOH and clinicopathologic features and its prognostic value for patients with stage II colon cancer. METHODS:A total of 106 samples of tumor tissues and corresponding normal mucosa from patients with sporadic stage-II colon cancer were included in this study. All the samples were formalin-fixed and paraffin-embedded. DNA was extracted from tumor tissues and LOH of D18S474, D18S55, D18S58, D18S61 and D18S64 at chromosome 18q was analyzed using polymerase chain reaction (PCR), polyacrylamide gel-electrophoresis, and DNA sequencing method. Multivariate analysis for association between LOH and prognosis in colon cancer patients was performed with Cox proportional hazards regression model. RESULTS:The median follow-up time was 68 months. For 106 patients, 5-year survival rate was 83.6%, which was associated with age and gross tumor type (P = 0.011 and 0.034, respectively). Among 102 patients who were eligible for LOH information, the overall frequency of LOH is 49.0% (50/102), and that of LOH at 5 microsatellite loci of D18S474, D18S55, D18S58, D18S61, and D18S64 was 30.2% (26/86), 23.4% (18/77), 28.6% (20/70), 35.0% (28/80), and 20.8%(15/72), respectively. The occurrence of LOH was significantly associated with tumor location and histopathologic grade (P = 0.023, 0.016 and 0.005, respectively). LOH was more frequent on the left-side, poorly-differentiated adenocarcinoma, and nonmucinous colon cancers. The occurrence of 18q-LOH was significantly associated with 5-year overall survival rate and disease free survival rate (P = 0.008 and 0.006, respectively). The occurrence of 18q-LOH at the loci of D18S474 and D18S61 was significantly associated with 5-year overall survival rate (P = 0.010 and 0.005, respectively). The multivariate analysis showed that only the occurrence of 18q-LOH was significantly associated with prognosis (P = 0.021). CONCLUSIONS:There is a high occurrence of LOH at the loci of 18q. The expression of LOH is significantly associated with tumor location and histopathologic grade. The occurrence of 18q-LOH is an independent poor prognostic factor for the patients with stage-II colon cancer.

Study on Loss of Heterozygosity of SMAD2 in Primary Gastric Carcinoma

Loss of heterozygosity of SMAD4/DPC4 in gastric carcinoma

Decreased Levels Of Active Smad2 Correlate With Poor Prognosis In Gastric Cancer

Loss of Heterozygosity and Abnormal Expression of MTSS1 in the Progression and Metastasis of Advanced Primary Gastric Carcinoma

Microsatellite Instability and Expression of hMSH2 mRNA in Gastric Cancer

Loss of OPCML Expression and the Correlation with CpG Island Methylation and LOH in Ovarian Serous Carcinoma.

Loss of Heterozygosity on Multiple Chromosomes in Patients with Esophageal Cancer and Its Clinical Significance

Loss of Heterozygosity on Chromosome 11p15.5 in Gastric Carcinoma in China

Microsatellite loss of heterozygosity in primary foci of recurrence laryngeal squamous cell carcinoma and its clinical significance

Loss of Heterozygosity and Abnormal Expressions of P53 and Nm23 in the Metastasis of Late Primary Gastrointestinal Carcinoma

Study on Loss of Heterozygosity and Microsatellite Instability in Hepatocellular Carcinoma

A study on the loss of heterozygosity at D9S171 locus in the primary tumor tissues and neck lymph nodes among cases with HNSCC

[The Changes and Significance of Microsatellite Loss of Heterozygosity in Laryngeal Premalignant Lesions and Squamous Cell Carcinoma].

Relationship Between the Loss of Heterozygosity of Nm23-H1 Gene and the Metastasis in Lung Cancer

Refined Mapping of Loss of Heterozygosity in Chinese Sporadic Gastric Carcinoma

The Study of Loss of Heterozygosity of D22S274 on 83 Sporadic Colorectal Carcinomas

Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of lymph node metastasis and gastric corpus cancer

Study on Loss of Heterozygosity at Microsatellite Locus in Larynx and Pharynx Squamous Cell Carcinoma and Neck Lymph Nodes

[Loss of Heterozygosity Analysis to Define Putative Region Involved in Tumor Differentiation and Metastases in Sporadic Colorectal Cancer Patients].

[Studies of Microsatellite Instability in Chinese Gastric Cancer Tissues].

Correlation analysis between loss of heterozygosity at chromosome 18q and prognosis in the stage-II colon cancer patients.